Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ aGVHD
aGVHD
13 registered clinical trials studyying aGVHD —
4 currently recruiting
.
Status
Trial
Sponsor
Phase
Not Yet Recruiting
A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched Transplanta
NCT07381114
Institute of Hematology & Blood Diseases Hospital, China
Phase 1 / Phase 2
Recruiting
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantati
NCT07246031
BioPhoenix Co., Ltd.
Phase 2
Not Yet Recruiting
Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease
NCT07185633
Bin Gu
Phase 2
Recruiting
Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
NCT06904482
Case Comprehensive Cancer Center
Phase 2
Unknown
Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Diseas
NCT05531266
Institute of Hematology & Blood Diseases Hospital, China
N/A
Terminated
A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus H
NCT05263999
Equillium
Phase 3
Completed
First Line Therapy for High Risk Acute GVHD
NCT04061876
Chinese PLA General Hospital
Phase 2
Completed
A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD
NCT03763318
Equillium
Phase 1 / Phase 2
Unknown
Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT
NCT05214066
Chinese PLA General Hospital
Phase 2
Completed
Low Dose Ruxolitinib in Combination With Methylprednisolone
NCT04397367
Chinese PLA General Hospital
Phase 1 / Phase 2
Unknown
Biomarker Study for Prediction of aGVHD
NCT03614143
Shanghai Jiao Tong University School of Medicine
—
Unknown
Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD
NCT02848105
Shanghai Jiao Tong University School of Medicine
Phase 2
Completed
Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT
NCT02677181
Chinese PLA General Hospital
Phase 4